IVERIC bio, Inc. (ISEE)
Chart Events
Performance Outlook
| Previous Close | 6.37 |
| Open | 6.30 |
| Bid | 6.46 x 900 |
| Ask | 6.49 x 800 |
| Day's Range | 6.30 - 6.51 |
| 52 Week Range | 3.22 - 7.98 |
| Volume | 169,940 |
| Avg. Volume | 641,270 |
| Market Cap | 582.496M |
| Beta (5Y Monthly) | 1.67 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.14 |
| Earnings Date | May 05, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 13.33 |
- Motley Fool
IVERIC bio, Inc. (ISEE) Q1 2021 Earnings Call Transcript
Representing Iveric Bio today are Glenn Sblendorio, chief executive officer; Pravin Dugel, president; David Carroll, chief financial officer; Dhaval Desai, chief development officer; Abraham Scaria, chief scientific officer; and Keith Westby, chief operating officer. In addition, any forward-looking statements represent our views only as of today and should not be relied upon as representing our views as of any subsequent date.
- Business Wire
Iveric Bio Reports First Quarter 2021 Operational Highlights and Financial Results
Iveric Bio announced financial and operating results for the quarter ended March 31, 2021 and provided a general business update.
- ACCESSWIRE
IVERIC bio, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / May 5, 2021 / IVERIC bio, Inc. (NASDAQ:ISEE) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 5, 2021 at 8:00 AM Eastern Time.
